Filing Details
- Accession Number:
- 0001179110-13-003170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-20 18:19:35
- Reporting Period:
- 2013-02-15
- Filing Date:
- 2013-02-20
- Accepted Time:
- 2013-02-20 18:19:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1452290 | J Michael Warmuth | 100 Abbott Park Road Abbott Park IL 60064-6400 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Disposition | 2013-02-19 | 6,452 | $35.08 | 38,618 | No | 4 | F | Direct | |
Common Shares Without Par Value | Disposition | 2013-02-19 | 2,800 | $34.78 | 35,818 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2013-02-19 | 266 | $34.78 | 35,552 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Acquisiton | 2013-02-15 | 149,600 | $0.00 | 149,600 | $34.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
149,600 | 2014-02-15 | 2023-02-14 | No | 4 | A | Direct |
Footnotes
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 49,867 on 2/15/2014, 49,866 on 2/15/2015, and 49,867 on 2/15/2016.